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Respiratory Management of Patients with ALS in Northern New England
Katie Davisson, Ariel Gallant-Bernstien, Mai Hoang, David Longstroth, Bryan Mason, Colleen Moran, Omar Ozgur, Abigail Woodhead,
With Dr. Rup Tandan of the University of Vermont College of Medicine and Christine Broderick of Northern New England ALS Association.

Background

Results

Conclusions

• Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s
disease, is a progressive neurodegenerative disease caused by the
degeneration of brain and spinal cord motor neurons, leading to steady
loss of voluntary muscle function and early death from respiratory
failure.

•120 surveys were mailed of which 64 were returned: 46 were usable, 9
were unusable due to incomplete information, and 9 were returned as
undeliverable.
•27 patients had attended a multidisciplinary ALS clinic at least once in the
last 12 months, and 19 had never attended a multidisciplinary clinic and
were followed by community‐based physicians.
•Comparison showed that the following data were not statistically
significant:
•52% of MDC patients versus 74% of CP patients reported
respiratory counseling.
•96% of MDC patients versus 71% CP patients reported having
respiratory function checked in the last 12 months (p=0.06).
•100% of MDC patients were using noninvasive ventilation, versus
63.6% of CP patients.
•Of those who had never been to a multidisciplinary clinic, the
incidence of pneumonia was 18% (versus 20% of those who had);
•ER visits for pneumonia was 9% (versus 10%);
•Use of antibiotics for chest infection was 18% (versus 30%);
•Admission to the hospital for pneumonia was 18% (versus
10%).
•37% of patients who attended a MDC in the last 12 months received
respiratory assistance and all were using non‐invasive ventilation.
•58% of those who received care by a CP were on respiratory support ‐
63.6% via non‐invasive ventilation and 36.4% via tracheostomy.

•ALS patients who were treated by CP’s were counseled about respiratory
function as frequently as patients seen in MDC, but they did not undergo
respiratory function testing as often.

• The incidence of ALS is 1‐2/100,000 population, the prevalence is 5‐
6/100,000 and approximately 30,000 people are living with ALS in the
United States.
• Currently there is no cure for ALS; treatment is focused on
symptomatic care and improving the quality of life.
• Most ALS patients in the United States are treated either at
multidisciplinary ALS centers/clinics in academic institutions or by
community‐based physicians / neurology practices.
• It is unclear if outcomes in patients with ALS are different among
those followed in multidisciplinary clinics(MDC) versus community
based physicians / neurology practices(CP).
• The goal of this project was to compare the type of respiratory
education and care received by patients with ALS from Northern New
England at MDC’s (Fletcher Allen and Dartmouth Medical Center)
versus CP.

Methods

•Greater use of invasive ventilation by patients followed by CP’s suggests that
in patients with advanced disease the ability to travel and attend
multidisciplinary clinics is limited.
•Since the survey sample size was small and few patients developed
respiratory events to obtain meaningful comparisons between groups, further
investigation is warranted.

• An anonymous, self‐administered questionnaire focused on respiratory
care management was mailed asking patients about the setting in which
they received the majority of care in the previous 12 months.
• The survey was distributed by the ALS Association’s Northern New
England Chapter to patients in Maine, New Hampshire, and Vermont, 50%
of total number of patients in the region.
• Survey responses were entered into a database and analyzed with specific
attention paid to the setting of care, counseling received, respiratory testing,
use of non‐invasive ventilation and frequency of adverse respiratory events.
• Patient data were sorted into two groups: those that had been seen one or
more times at the MDC versus those that had never been seen at the clinic
but were followed by CP’s. Fisher’s Exact test was used (alpha = 0.05, 2
tailed) to compare the proportions of “yes” responses from the two groups.
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